MLYS

$0.00

(

0.00%

)
Quote details

stock

Mineralys Therapeutics, Inc. Common Stock

NASDAQ | MLYS

28.73

USD

$0.00

(

0.00%

)

At Close (As of Sep 3, 2025)

$1.91B

Market Cap

-

P/E Ratio

-3.56

EPS

$30.14

52 Week High

$8.24

52 Week Low

LIFE SCIENCES

Sector

MLYS Chart

Recent Chart
Price Action

MLYS Technicals

Tags:

MLYS Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$43K
Total Revenue $0
Cost Of Revenue $43K
Costof Goods And Services Sold $43K
Operating Income -$192M
Selling General And Administrative $24M
Research And Development $169M
Operating Expenses $192M
Investment Income Net -
Net Interest Income $15M
Interest Income $15M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $43K
Income Before Tax -$178M
Income Tax Expense -$178M
Interest And Debt Expense -
Net Income From Continuing Operations -$178M
Comprehensive Income Net Of Tax -
Ebit -$192M
Ebitda -$192M
Net Income -$178M

Revenue & Profitability

Earnings Performance

MLYS Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $206M
Total Current Assets $205M
Cash And Cash Equivalents At Carrying Value $114M
Cash And Short Term Investments $114M
Inventory -
Current Net Receivables -
Total Non Current Assets $552K
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $0
Short Term Investments $84M
Other Current Assets $7.2M
Other Non Current Assets -
Total Liabilities $15M
Total Current Liabilities $15M
Current Accounts Payable $479K
Deferred Revenue -
Current Debt -
Short Term Debt -
Total Non Current Liabilities $0
Capital Lease Obligations -
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total -
Other Current Liabilities $14M
Other Non Current Liabilities -
Total Shareholder Equity $191M
Treasury Stock -
Retained Earnings -$303M
Common Stock $5K
Common Stock Shares Outstanding $49M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$166M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $43K
Capital Expenditures $96K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $115M
Cashflow From Financing $116M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity $221K
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$178M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$43K
Total Revenue $0
Cost Of Revenue $43K
Costof Goods And Services Sold $43K
Operating Income -$192M
Selling General And Administrative $24M
Research And Development $169M
Operating Expenses $192M
Investment Income Net -
Net Interest Income $15M
Interest Income $15M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $43K
Income Before Tax -$178M
Income Tax Expense -$178M
Interest And Debt Expense -
Net Income From Continuing Operations -$178M
Comprehensive Income Net Of Tax -
Ebit -$192M
Ebitda -$192M
Net Income -$178M

MLYS News

MLYS Profile

Mineralys Therapeutics, Inc. Common Stock Profile

Sector: LIFE SCIENCES

Industry: PHARMACEUTICAL PREPARATIONS

Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and associated cardiovascular diseases. The company is headquartered in Radnor, Pennsylvania.

CGBS
-39.47%
$0.03
BURU
+3.08%
$0.16
AIHS
+130.87%
$5.54
BTBD
+74.89%
$3.23
NVDA
+0.21%
$171.14
TPIC
-45.91%
$0.12
AXDX
-61.36%
$0.03
GOOGL
+8.17%
$228.63
LYT
-16.77%
$0.09
BINI
-8.13%
$0.19
NIO
-7.14%
$6.11
SNAP
-1.41%
$7.22
VHAI
0.00%
$0.00
TSLA
+3.53%
$340.99
PMN
-12.41%
$0.47
UGRO
+24.98%
$0.50
NXTT
+10.70%
$0.28
GOOG
+8.48%
$229.98
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
SINT
+10.14%
$5.03
SRM
+53.27%
$10.30
PLTR
+1.13%
$158.87
AAL
+0.96%
$13.51
TLRY
-6.30%
$1.17
AAPL
+2.64%
$235.79
M
+16.74%
$15.74
DNN
+2.41%
$2.33
RIVN
+7.31%
$14.88
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
BAOS
+31.92%
$3.76
CJET
-64.00%
$0.21
WLGS
-5.57%
$0.04
ETWO
0.00%
$3.30
PLUG
+2.36%
$1.51
BMNR
+6.39%
$45.20
INTC
-1.28%
$23.90
SOFI
-0.56%
$24.76
GDXD
-7.87%
$1.52
AFMD
-34.94%
$0.18
SOUN
-2.20%
$13.12
MARA
-0.43%
$15.99
RIOT
-2.75%
$13.70
IXHL
-3.99%
$0.61
RAYA
-8.13%
$0.04
CIFR
-0.54%
$8.27
LYFT
+4.16%
$17.49
IPDN
+11.36%
$7.74
BITF
-0.37%
$1.33
IREN
-0.48%
$28.97
GRYP
-10.38%
$1.38
BTG
-2.32%
$4.17
SMR
+12.03%
$41.72
MODV
-25.22%
$0.43
JOBY
-1.53%
$13.17
ADAP
-5.01%
$0.05
ABEV
-1.82%
$2.15
NOK
+3.19%
$4.36
ETHD
-9.81%
$3.33
MULN
-20.26%
$0.20
AMD
-0.40%
$161.67
RKLB
-7.80%
$45.46
WBD
-0.38%
$11.57
F
-0.66%
$11.64
WULF
-4.41%
$9.20
BBD
-0.20%
$3.01
HIMS
+8.18%
$44.93
SBET
-0.26%
$16.93
RZLV
+10.35%
$4.04
URG
+11.31%
$1.52
ZAPP
-46.30%
$0.15
MRVL
-3.82%
$62.13
AEI
+19.14%
$1.93
ONDS
-1.00%
$5.40
HOOD
+0.51%
$101.36
CARM
-12.61%
$0.38
RR
-4.62%
$2.75
BTE
-3.83%
$2.26
STTK
+24.25%
$1.25
GEG
+17.96%
$3.02
BTBT
-1.34%
$2.57
QBTS
+0.19%
$15.88
KDP
-0.15%
$28.86
PFE
-0.80%
$24.77
ASBP
-4.62%
$0.54
CGC
-5.55%
$1.40
AMZN
+0.18%
$225.76
LCID
-2.91%
$17.14
BAC
-0.78%
$50.02
HL
0.00%
$8.92
ATNF
-4.98%
$2.67
BABA
-0.84%
$137.38
VZ
-0.98%
$43.36
LCFY
+13.63%
$4.62
RGTI
+0.17%
$15.54
T
-0.66%
$28.88
KEY
-0.44%
$18.87
CRWV
-2.64%
$90.87
KO
-0.10%
$68.98
CGBS
-39.47%
$0.03
BURU
+3.08%
$0.16
AIHS
+130.87%
$5.54
BTBD
+74.89%
$3.23
NVDA
+0.21%
$171.14
TPIC
-45.91%
$0.12
AXDX
-61.36%
$0.03
GOOGL
+8.17%
$228.63
LYT
-16.77%
$0.09
BINI
-8.13%
$0.19
NIO
-7.14%
$6.11
SNAP
-1.41%
$7.22
VHAI
0.00%
$0.00
TSLA
+3.53%
$340.99
PMN
-12.41%
$0.47
UGRO
+24.98%
$0.50
NXTT
+10.70%
$0.28
GOOG
+8.48%
$229.98
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
SINT
+10.14%
$5.03
SRM
+53.27%
$10.30
PLTR
+1.13%
$158.87
AAL
+0.96%
$13.51
TLRY
-6.30%
$1.17
AAPL
+2.64%
$235.79
M
+16.74%
$15.74
DNN
+2.41%
$2.33
RIVN
+7.31%
$14.88
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
BAOS
+31.92%
$3.76
CJET
-64.00%
$0.21
WLGS
-5.57%
$0.04
ETWO
0.00%
$3.30
PLUG
+2.36%
$1.51
BMNR
+6.39%
$45.20
INTC
-1.28%
$23.90
SOFI
-0.56%
$24.76
GDXD
-7.87%
$1.52
AFMD
-34.94%
$0.18
SOUN
-2.20%
$13.12
MARA
-0.43%
$15.99
RIOT
-2.75%
$13.70
IXHL
-3.99%
$0.61
RAYA
-8.13%
$0.04
CIFR
-0.54%
$8.27
LYFT
+4.16%
$17.49
IPDN
+11.36%
$7.74
BITF
-0.37%
$1.33
IREN
-0.48%
$28.97
GRYP
-10.38%
$1.38
BTG
-2.32%
$4.17
SMR
+12.03%
$41.72
MODV
-25.22%
$0.43
JOBY
-1.53%
$13.17
ADAP
-5.01%
$0.05
ABEV
-1.82%
$2.15
NOK
+3.19%
$4.36
ETHD
-9.81%
$3.33
MULN
-20.26%
$0.20
AMD
-0.40%
$161.67
RKLB
-7.80%
$45.46
WBD
-0.38%
$11.57
F
-0.66%
$11.64
WULF
-4.41%
$9.20
BBD
-0.20%
$3.01
HIMS
+8.18%
$44.93
SBET
-0.26%
$16.93
RZLV
+10.35%
$4.04
URG
+11.31%
$1.52
ZAPP
-46.30%
$0.15
MRVL
-3.82%
$62.13
AEI
+19.14%
$1.93
ONDS
-1.00%
$5.40
HOOD
+0.51%
$101.36
CARM
-12.61%
$0.38
RR
-4.62%
$2.75
BTE
-3.83%
$2.26
STTK
+24.25%
$1.25
GEG
+17.96%
$3.02
BTBT
-1.34%
$2.57
QBTS
+0.19%
$15.88
KDP
-0.15%
$28.86
PFE
-0.80%
$24.77
ASBP
-4.62%
$0.54
CGC
-5.55%
$1.40
AMZN
+0.18%
$225.76
LCID
-2.91%
$17.14
BAC
-0.78%
$50.02
HL
0.00%
$8.92
ATNF
-4.98%
$2.67
BABA
-0.84%
$137.38
VZ
-0.98%
$43.36
LCFY
+13.63%
$4.62
RGTI
+0.17%
$15.54
T
-0.66%
$28.88
KEY
-0.44%
$18.87
CRWV
-2.64%
$90.87
KO
-0.10%
$68.98

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.